These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37369021)

  • 1. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
    Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
    Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
    Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
    Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Serine Treatment is Associated with Improvements in Behavior, EEG, and Seizure Frequency in Individuals with GRIN-Related Disorders Due to Null Variants.
    Krey I; von Spiczak S; Johannesen KM; Hikel C; Kurlemann G; Muhle H; Beysen D; Dietel T; Møller RS; Lemke JR; Syrbe S
    Neurotherapeutics; 2022 Jan; 19(1):334-341. PubMed ID: 34997442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for Precision Treatment of
    Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
    J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
    Korinek M; Candelas Serra M; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A; Smejkalova T
    Physiol Res; 2024 May; 73(Suppl 1):S413-S434. PubMed ID: 38836461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
    Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
    Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
    Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
    Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Mice Carrying a Neurodevelopmental Disease-Associated GluN2B(L825V) Variant.
    Candelas Serra M; Kuchtiak V; Kubik-Zahorodna A; Kysilov B; Fili K; Hrcka Krausova B; Abramova V; Dobrovolski M; Harant K; Bozikova P; Cerny J; Prochazka J; Kasparek P; Sedlacek R; Balik A; Smejkalova T; Vyklicky L
    J Neurosci; 2024 Jul; 44(31):. PubMed ID: 38926089
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
    Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
    Kellner S; Berlin S
    Cell Mol Life Sci; 2024 May; 81(1):235. PubMed ID: 38795169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRIN database: A unified and manually curated repertoire of GRIN variants.
    García-Recio A; Santos-Gómez A; Soto D; Julia-Palacios N; García-Cazorla À; Altafaj X; Olivella M
    Hum Mutat; 2021 Jan; 42(1):8-18. PubMed ID: 33252190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of NMDA Receptor Variants in Neurodevelopmental Disorders and Epilepsy.
    Gjerulfsen CE; Krey I; Klöckner C; Rubboli G; Lemke JR; Møller RS
    Methods Mol Biol; 2024; 2799():1-11. PubMed ID: 38727899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder.
    den Hollander B; Veenvliet ARJ; Rothuizen-Lindenschot M; van Essen P; Peters G; Santos-Gómez A; Olivella M; Altafaj X; Brands MM; Jacobs BAW; van Karnebeek CD
    Mol Genet Metab; 2023 Mar; 138(3):107523. PubMed ID: 36758276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two
    Kellner S; Abbasi A; Carmi I; Heinrich R; Garin-Shkolnik T; Hershkovitz T; Giladi M; Haitin Y; Johannesen KM; Steensbjerre Møller R; Berlin S
    Elife; 2021 Jul; 10():. PubMed ID: 34212862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distances from ligands as main predictive features for pathogenicity and functional effect of variants in NMDA receptors.
    Montanucci L; Brünger T; Bhattarai N; Boßelmann CM; Kim S; Allen JP; Zhang J; Klöckner C; Fariselli P; May P; Lemke JR; Myers SJ; Yuan H; Traynelis SF; Lal D
    medRxiv; 2024 May; ():. PubMed ID: 38766179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.